They might have been against it then but maybe sutuation has changed now? Currently the reality seems to be they have proven safety in phase 1 but other than that do we have any official data on safety in infected humans. As far as i am aware still no trial data on actually treating an infection safely in a human trial participant? To date just the emergency access sinusitis case and early promising data on burns that has now disappeared.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)